ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.
1282 health care and life sciences companies are in the directory, 159 of them in the same 51-100 employee range and 184 based in European Union (EU).
Abionyx Pharma may be growing as the company has released its full-year financial results for 2023, which typically includes key financial performance indicators such as revenue, profit, and cash flow. Additionally, the company has provided an update on its activity and cash position for the first quarter of 2024, suggesting ongoing operations and financial transparency. The announcement of a financial calendar for the year 2024 indicates forward planning and a structured approach to financial reporting, which can be positive signs of a company's organizational growth and stability.
“Abionyx : A new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. ABIONYX plans to explore joint activities with attractive partners.” abionyx.com
Abionyx Pharma is a biotechnology company based in European Union (EU), with 51-100 employees, founded in 2005. Its website drew about 2,308 visits in the latest month measured and it has raised $155.3 million over 5 rounds.
51-100 employees · ahn-bio.de
51-100 employees · aoporphan.com
51-100 employees · 4basebio.com
101-250 employees · abivax.com
51-100 employees · 1859.ai
51-100 employees · als.net
51-100 employees · abeonatherapeutics.com
51-100 employees · acutis.com
51-100 employees · acrivon.com
51-100 employees · abingdonhealth.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.